Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Thyroid Neoplasms × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Medullary 1

Interventions

selpercatinib 2 repotrectinib 1 pralsetinib 1 pembrolizumab 1 larotrectinib 1 cabozantinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡